-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Skye Bioscience, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2012 to Q2 2024.
- Skye Bioscience, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $8.07K, a 124% increase year-over-year.
- Skye Bioscience, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $10.1K.
- Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2023 was $3.6K, a 46.6% decline from 2022.
- Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2022 was $6.74K, a 221% increase from 2021.
- Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.1K, a 31.3% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)